Paper Details
- Home
- Paper Details
Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns.
Author: BagnoliFranco, CasucciMartina, MessinaGabriele, MoriAnnalisa, RossettiAnnalisa, TomasiniBarbara
Original Abstract of the Article :
OBJECTIVES: This study aims to determine whether or not treatment of preterm neonates with PDA using IV ibuprofen can impair renal function and in what range of birth weights and gestational ages the risk of major renal side-effects due to ibuprofen is highest. METHODS: 134 preterm newborns with PD...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.3109/14767058.2012.733775
データ提供:米国国立医学図書館(NLM)
Ibuprofen for Patent Ductus Arteriosus: A Balancing Act in Preterm Neonates
The care of preterm neonates is a delicate dance, navigating the need for treatment while minimizing potential risks. This study explores the use of ibuprofen for treating patent ductus arteriosus (PDA) in preterm newborns, specifically looking at the potential for renal side effects. The researchers conducted a randomized trial to assess the impact of ibuprofen on renal function in preterm infants with varying birth weights and gestational ages. Their findings suggest that ibuprofen can impair renal function, particularly in infants with lower birth weights and gestational ages, highlighting the importance of carefully weighing the risks and benefits of this treatment. The study serves as a reminder that navigating the desert of neonatal medicine requires careful consideration of each patient's unique circumstances.
Ibuprofen: A Double-Edged Sword in Preterm Neonatal Care
This study highlights the complex considerations involved in treating preterm neonates, particularly when it comes to medications with potential side effects. The findings underscore the importance of individualized treatment plans, taking into account factors such as birth weight, gestational age, and the severity of the condition. The study serves as a valuable guide for clinicians navigating the delicate balance between treatment efficacy and potential risks in preterm neonatal care.
Navigating the Desert of Preterm Neonatal Care: What to Keep in Mind
If you have a preterm baby, working closely with your pediatrician is essential. They will be able to monitor your baby's health, provide appropriate care, and make informed decisions about treatment options. It's important to be aware of potential risks and benefits associated with different treatments and to communicate openly with your pediatrician about any concerns you may have. Together, you can navigate the challenges of preterm neonatal care and ensure the best possible outcome for your little one.
Dr. Camel's Conclusion
This study highlights the delicate balance involved in treating preterm neonates, emphasizing the importance of careful consideration of each patient's unique circumstances. The study serves as a reminder that navigating the desert of neonatal medicine requires a skilled guide and a compassionate heart.
Date :
- Date Completed 2013-07-22
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.